Home Healthcare Pharmaceuticals Contrast Media Market

Contrast Media Market Size, Share & Trends Analysis Report By Product (Microbubble Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, Barium-based Contrast Media), By Modality (Ultrasound, Magnetic Resonance Imaging, X-ray/Computed Tomography), By Applications (Cardiovascular, Neurological Disorders, Gastrointestinal Disorders, Cancer, Nephrological Disorders, Musculoskeletal Disorders, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Contrast Media Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Microbubble Contrast Media
    2. Gadolinium-based Contrast Media
    3. Iodinated Contrast Media
    4. Barium-based Contrast Media
  2. Contrast Media Market, By Modality 2022-2034 (USD MILLION/ Units)
    1. Ultrasound
    2. Magnetic Resonance Imaging
    3. X-ray/Computed Tomography
  3. Contrast Media Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Cardiovascular
    2. Neurological Disorders
    3. Gastrointestinal Disorders
    4. Cancer
    5. Nephrological Disorders
    6. Musculoskeletal Disorders
    7. Others
  4. Regional Contrast Media Market
    1. North America
      1. North America Contrast Media Market By Product 2022-2034 (USD MILLION/ Units)
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
      2. North America Contrast Media Market By Modality 2022-2034 (USD MILLION/ Units)
        1. Ultrasound
        2. Magnetic Resonance Imaging
        3. X-ray/Computed Tomography
      3. North America Contrast Media Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular
        2. Neurological Disorders
        3. Gastrointestinal Disorders
        4. Cancer
        5. Nephrological Disorders
        6. Musculoskeletal Disorders
        7. Others
      4. U.S.
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      5. Canada
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
    2. Europe
      1. Europe Contrast Media Market By Product 2022-2034 (USD MILLION/ Units)
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
      2. Europe Contrast Media Market By Modality 2022-2034 (USD MILLION/ Units)
        1. Ultrasound
        2. Magnetic Resonance Imaging
        3. X-ray/Computed Tomography
      3. Europe Contrast Media Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular
        2. Neurological Disorders
        3. Gastrointestinal Disorders
        4. Cancer
        5. Nephrological Disorders
        6. Musculoskeletal Disorders
        7. Others
      4. U.K.
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      5. Germany
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      6. France
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      7. Spain
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      8. Italy
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      9. Russia
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      10. Nordic
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      11. Benelux
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      12. Rest of Europe
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
    3. APAC
      1. APAC Contrast Media Market By Product 2022-2034 (USD MILLION/ Units)
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
      2. APAC Contrast Media Market By Modality 2022-2034 (USD MILLION/ Units)
        1. Ultrasound
        2. Magnetic Resonance Imaging
        3. X-ray/Computed Tomography
      3. APAC Contrast Media Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular
        2. Neurological Disorders
        3. Gastrointestinal Disorders
        4. Cancer
        5. Nephrological Disorders
        6. Musculoskeletal Disorders
        7. Others
      4. China
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      5. Korea
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      6. Japan
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      7. India
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      8. Australia
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      9. Singapore
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      10. Taiwan
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      11. South East Asia
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      12. Rest of Asia-Pacific
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Contrast Media Market By Product 2022-2034 (USD MILLION/ Units)
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
      2. Middle East and Africa Contrast Media Market By Modality 2022-2034 (USD MILLION/ Units)
        1. Ultrasound
        2. Magnetic Resonance Imaging
        3. X-ray/Computed Tomography
      3. Middle East and Africa Contrast Media Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular
        2. Neurological Disorders
        3. Gastrointestinal Disorders
        4. Cancer
        5. Nephrological Disorders
        6. Musculoskeletal Disorders
        7. Others
      4. UAE
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      5. Turkey
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      6. Saudi Arabia
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      7. South Africa
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      8. Egypt
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      9. Nigeria
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      10. Rest of MEA
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
    5. LATAM
      1. LATAM Contrast Media Market By Product 2022-2034 (USD MILLION/ Units)
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
      2. LATAM Contrast Media Market By Modality 2022-2034 (USD MILLION/ Units)
        1. Ultrasound
        2. Magnetic Resonance Imaging
        3. X-ray/Computed Tomography
      3. LATAM Contrast Media Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cardiovascular
        2. Neurological Disorders
        3. Gastrointestinal Disorders
        4. Cancer
        5. Nephrological Disorders
        6. Musculoskeletal Disorders
        7. Others
      4. Brazil
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      5. Mexico
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      6. Argentina
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      7. Chile
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      8. Colombia
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
      9. Rest of LATAM
        1. Microbubble Contrast Media
        2. Gadolinium-based Contrast Media
        3. Iodinated Contrast Media
        4. Barium-based Contrast Media
        5. Ultrasound
        6. Magnetic Resonance Imaging
        7. X-ray/Computed Tomography
        8. Cardiovascular
        9. Neurological Disorders
        10. Gastrointestinal Disorders
        11. Cancer
        12. Nephrological Disorders
        13. Musculoskeletal Disorders
        14. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.